25437-94-9

Basic information

• Product Name: 4-(4-Hydroxy-1-piperidinyl)ethyl benzoate
• Synonyms: 4-(4-Hydroxy-1-piperidinyl)ethyl benzoate
• CAS NO: 25437-94-9
• Molecular Formula: C₁₄H₁₉NO₃
• Molecular Weight: 249.31
• Mol File: 25437-94-9.mol
• Article Data: 11

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-(4-Hydroxy-1-piperidinyl)ethyl benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4-Hydroxy-1-piperidinyl)ethyl benzoate(25437-94-9)
• EPA Substance Registry System: 4-(4-Hydroxy-1-piperidinyl)ethyl benzoate(25437-94-9)

Safety Data

• Hazardous Substances Data: 25437-94-9(Hazardous Substances Data)

Usage

General Description

4-(4-Hydroxy-1-piperidinyl)ethyl benzoate is a chemical compound that is commonly used in the pharmaceutical industry as an intermediate for the synthesis of various drugs. It is a derivative of benzoic acid and contains a piperidine ring, which makes it a potential candidate for pharmaceutical applications. 4-(4-Hydroxy-1-piperidinyl)ethyl benzoate has been studied for its potential use in the treatment of various medical conditions, including neurological and psychiatric disorders. It has also been investigated for its antioxidant and anti-inflammatory properties, which may have potential therapeutic applications. However, further research is needed to fully understand the potential uses and applications of this compound in the pharmaceutical industry.

Upstream product

• 5382-16-1 4-HYDROXYPIPERIDINE 
• 451-46-7 4-fluorobenzoic acid ethyl ester 

Downstream Products

• 25437-95-0 4-(4-Oxo-1-piperidinyl)benzoic acid ethyl ester 
• 247034-87-3 ethyl 4-(4-phthalimidopiperidin-1-yl)benzoate 
• 247034-88-4 ethyl 4-(4-aminopiperidin-1-yl)benzoate 
• 247034-90-8 4-{4-(Pyrimidin-2-ylamino)piperidin-1-yl}benzoic acid 
• 247034-89-5 ethyl 4-{4-(pyrimidin-2-ylamino)piperidin-1-yl}benzoate 
• 247033-64-3 (2S)-benzenesulfonylamino-3-[4-{4-(pyrimidin-2-ylamino)piperidin-1-yl}benzoylamino]propionic acid 
• 247033-63-2 tert-butyl (2S)-benzenesulfonylamino-3-[4-{4-(pyrimidin-2-ylamino)piperidin-1-yl}benzoylamino]propionate 
• 247035-04-7 4-[4-{(tert-butoxycarbonyl)amino}piperidin-1-yl]benzoic acid 
• 883726-98-5 4-{4-(4,5-dihydro-1H-imidazol-2-ylamino)piperidin-1-yl}benzoic acid 
• 329280-10-6 4-tert-butoxycarbonylamino-1-(4-ethoxycarbonyl-phenyl)piperidine 
• 247035-09-2 ethyl 4-{4-(4,5-dihydro-1H-imidazol-2-ylamino)piperidin-1-yl}benzoate 
• 883727-01-3 4-{4-(4,5,6,7-tetrahydro-1H-[1,3]diazepin-2-ylamino)piperidin-1-yl}benzoic acid 
• 247035-13-8 ethyl 4-{4-(4,5,6,7-tetrahydro-1H-[1,3]diazepin-2-ylamino)piperidin-1-yl}benzoate 
• 324781-26-2 (2S)-hydroxy-3-[4-{4-(pyrimidin-2-ylamino)-piperidin-1-yl}benzoylamino]propionic acid 

Relevant articles and documents

IRAK DEGRADERS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same.

Anti-inflammatory agents

Disclosed are novel compounds that are useful in regulating the expression of interleukin-6 (IL-6) and/or vascular cell adhesion molecule-1 (VCAM-1), and their use in the treatment and/or prevention of cardiovascular and inflammatory diseases and related disease states, such as, for example, atherosclerosis, asthma, arthritis, cancer, multiple sclerosis, psoriasis, and inflammatory bowel diseases, and autoimmune disease(s). Also, disclosed are compositions comprising the novel compounds, as well as methods for their preparation.

POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITORS

Compounds of the following formula are provided for use in inhibiting Poly (ADP-ribose) Polymerase (PARP): wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds,